Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PPH

VanEck Pharmaceutical ETF

Dec 11 • 04:00PM ET

88.67

Dollar change -0.36
Percentage change -0.40	%

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	15.56%	Shs Outstand		Perf Week	-1.59%
Sponsor	Van Eck Associates Corporation	ETF Type		Tags	equity	Return% 3Y	9.06%	Total Holdings	27	Perf Month	-2.23%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	9.27%	AUM	603.80M	Perf Quarter	-8.87%
Index	MVIS US Listed Pharmaceutical 25 Index	Average Maturity		Tags	pharmaceutical	Return% 10Y		NAV%		Perf Half Y	-3.66%
Index Weighting		Commodity Type		Tags	-	Return% SI		NAV/sh		Perf Year	12.85%
Active/Passive		Quant Type		Tags	-	Flows% 1M	-6.87%	52W Range	78.19 - 99.51	Perf YTD	8.98%
Dividend TTM	1.60 (1.81%)	ESG Type		Tags	-	Flows% 3M	-9.42%	52W High	-10.89%	Beta	0.63
Dividend Ex-Date	Oct 01, 2024	Dividend Type		Sector/Theme		Flows% YTD	24.71%	52W Low	13.40%	ATR (14)	0.83
Expense	0.36%	Structure Type		Region		Flows% 1Y		RSI (14)	38.93	Volatility	0.81% 0.84%
Option/Short	Yes / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	0.38	Prev Close	89.03
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	183.75K	Price	88.67
SMA20	-0.31%	SMA50	-2.76%	SMA200	-3.27%	Trades		Volume	69,215	Change	-0.40%

Sep-20-22 03:13PM	Best Pharmaceutical ETFs for Q4 2022 (Investopedia)
Mar-26-22 10:00PM	When Should You Buy Pushpay Holdings Limited (NZSE:PPH)? (Simply Wall St.)
Jan-24-22 01:38PM	Altfest L J & Co Inc Buys iShares 0-5 Year TIPS Bond ETF, ISHARES TRUST, iShares U.S. ... (GuruFocus.com)
Dec-14-21 10:38PM	VanEck Africa Index ETF Buys Helios Towers PLC, Capitec Bank Holdings, First Quantum Minerals, ... (GuruFocus.com)
May-22-20 07:46AM	Telehealth is going to 'become the default' for patients: Ro CEO (Yahoo Finance)
10:03AM	Loading…
May-18-20 10:03AM	3 ETFs in Focus as Race for Vaccine Intensifies (Investopedia)
Apr-09-20 10:10AM	Top-Ranked ETFs & Stocks to Buy From Bargain Industries (Zacks)
Feb-07-20 11:05AM	Pharma ETFs Gain on Healthy Q4 Earnings (Zacks)
Jan-22-20 01:00PM	Sector ETFs & Stocks to Gain/Lose on Coronavirus Outbreak (Zacks)
Dec-20-19 08:10AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Dec-05-19 03:34PM	Hedge Funds Are Warming Up To GlaxoSmithKline plc (GSK) (Insider Monkey)
Nov-22-19 05:15PM	VanEck Announces Preliminary Yearend Distribution Estimates for VanEck Vectors ETFs (Business Wire)
Nov-08-19 08:00AM	Pharma Sector Tops in October: Best ETFs & Stocks (Zacks)
Nov-06-19 11:00AM	Pharma ETFs Set to Benefit Post Strong Q3 Earnings (Zacks)
Sep-30-19 06:04PM	Announcing VanEck Vectors ETFs September 2019 Distributions (Business Wire)
11:27AM	Loading…
Sep-23-19 11:27AM	Pharma ETFs Boosted After Senate Rejects House Drug Pricing Plan (ETF Trends)
Sep-09-19 02:09PM	10 ETFs That Could Be Primed For A Short Squeeze (Benzinga)
Aug-22-19 11:12AM	8 ETFs to Capture Opportunities in Healthcare Sector (ETF Trends)
Aug-07-19 10:59AM	Pharma Q2 Earnings Growth Highest: Time to Buy ETFs? (Zacks)
Jun-28-19 06:01PM	Announcing VanEck Vectors ETFs June 2019 Distributions (Business Wire)
Jun-26-19 11:00AM	AbbVie to Buy Allergan: Prescribed ETFs (Zacks)
Jun-25-19 06:01PM	AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs (ETF Trends)
May-14-19 05:40PM	Legal Troubles Beset Pharmaceutical Sector ETFs (ETF Trends)
May-09-19 10:05AM	Pharma ETFs Down Despite Solid Q1 Results (Zacks)
Apr-30-19 12:59PM	Disruptive GW Pharmaceuticals Is Exempt from Big Pharmas Volatility (InvestorPlace)
Mar-29-19 06:42PM	Announcing VanEck Vectors ETFs March 2019 Distributions (Business Wire)
Mar-21-19 07:56AM	Does Recent Weakness in AbbVie Stock Make It a Buy? 3 Pros, 3 Cons (InvestorPlace)
Feb-21-19 10:08AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Feb-07-19 11:15AM	A Look at Pharma ETFs Post Q4 Results (Zacks)
Jan-29-19 09:08AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
09:27AM	Loading…
Jan-07-19 09:27AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Dec-26-18 06:37PM	Announcing VanEck Vectors Equity ETFs December 2018 Distribution (Business Wire)
Dec-14-18 09:28AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Dec-10-18 10:33AM	Dont Punish Gilead Stock for Doing Its Job (InvestorPlace)
Nov-16-18 05:52PM	VanEck Announces Preliminary Yearend Distribution Estimates for VanEck Vectors Equity ETFs (Business Wire)
Oct-24-18 11:59AM	ETF Strategies for the Midterm Elections (Zacks)
Oct-17-18 11:48AM	VanEck Launches ESPO, ETF Focused on Fast Growing Video Game and eSports Industry (Business Wire)
Oct-12-18 06:00AM	Top 5 Pharmaceutical ETFs for 2018 (Investopedia)
Oct-09-18 11:39AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Sep-28-18 06:03PM	Announcing VanEck Vectors Equity ETFs September 2018 Distributions (Business Wire)
Jul-03-18 03:19PM	July Could Be a Volatile Month for Pharma ETFs (ETF Trends)
Jun-29-18 06:15PM	Announcing VanEck Vectors Equity ETFs June 2018 Distributions (Business Wire)
Jun-04-18 10:38AM	Biogen Inc Stock Got an Upgrade, but Should You Listen? (InvestorPlace)
Apr-24-18 06:41AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Mar-29-18 05:58PM	Announcing VanEck Vectors Equity ETFs March 2018 Distributions (Business Wire)
Jan-25-18 09:00AM	Tasigna Could Boost Novartiss Revenue Growth in 2018 (Market Realist)
07:31AM	Novartis Receives 2 Breakthrough Therapy Designations in January (Market Realist)
Jan-22-18 10:00AM	Behind Novartiss 4Q17 Earnings: Why Some Expect Revenue Growth (Market Realist)
07:34AM	Johnson & Johnsons Consumer Segment: 4Q17 Estimates (Market Realist)
Jan-15-18 10:31AM	How Teva Pharmaceutical Is Realigning Organizational Structure (Market Realist)
Jan-10-18 12:03PM	Mylans Valuation in January 2018 (Market Realist)
Jan-09-18 10:31AM	Valeant on the Street: Analyst Recommendations in December 2017 (Market Realist)
Jan-08-18 07:33AM	How Did Novo Nordisks NovoMix and Human Insulin Perform in 2017? (Market Realist)
Jan-05-18 10:35AM	How Novo Nordisks Biopharmaceuticals Segment Performed in 3Q17 (Market Realist)
Dec-26-17 06:15PM	Announcing VanEck Vectors Equity ETFs December 2017 Distributions (Business Wire)
Nov-22-17 05:30PM	VanEck Announces Preliminary Yearend Distribution Estimates for VanEck Vectors Equity ETFs (Business Wire)
Nov-14-17 02:35PM	Understanding Sanofis Revenues by Segment in 3Q17 (Market Realist)
Oct-16-17 12:33PM	President Trump reiterates that drug companies 'getting away with murder' but says not much else (MarketWatch)
Oct-02-17 12:35PM	CORRECTING and REPLACING Announcing VanEck Vectors Equity ETFs September 2017 Distributions (Business Wire)
Sep-29-17 05:25PM	Announcing VanEck Vectors Equity ETFs September 2017 Distributions (Business Wire)
Sep-20-17 10:36AM	Why Cosentyx Could Significantly Drive Novartiss Revenue Growth (Market Realist)
Sep-19-17 10:38AM	An Update on Novartiss Sandostatin, Afinitor, and Exjade (Market Realist)
Sep-14-17 07:39AM	TEVA Depends on This for Revenue Growth (Market Realist)
Sep-11-17 10:36AM	How Mercks Gardasil and Other Human Vaccines Performed in 2Q17 (Market Realist)
07:36AM	Where Jazz Pharmaceuticals Erwinaze and Prialt Are Positioned after 2Q17 (Market Realist)
Sep-06-17 09:06AM	Performance of AstraZenecas Other Products in 2Q17 (Market Realist)
Sep-05-17 07:37AM	Performance of AstraZenecas Growth Platforms in 2Q17 (Market Realist)
Sep-04-17 09:06AM	Performance of Eli Lillys Neuroscience Products in 2Q17 (Market Realist)
Aug-31-17 12:34PM	Changes in GlaxoSmithKlines Valuation after 2Q17 (Market Realist)
07:38AM	How Novartiss Sandoz Performed in 2Q17 (Market Realist)
Aug-30-17 07:36AM	Johnson & Johnsons Medical Devices Segment in 2Q17 (Market Realist)
Aug-23-17 11:53AM	JAZZ Is Focused on Increasing Market Adoption of Defitelio (Market Realist)
09:53AM	Jazz Pharmaceuticals Is Focused on Label Expansion of Defitelio (Market Realist)
Aug-21-17 04:05PM	Inside Jazzs Net Profit Margin Expectations for 2017 (Market Realist)
Aug-17-17 07:37AM	Sanofis Revenue Growth in 2Q17 (Market Realist)
Aug-15-17 09:06AM	Pfizers Important Product Developments in 2Q17 (Market Realist)
Aug-14-17 10:25AM	Why Vertex Pharmaceuticals Incorporated (VRTX) Stock Isnt Worth the Risk (InvestorPlace)
Aug-07-17 09:53AM	How Valeant Pharmaceuticals Intl Inc (VRX) Stock Can Make a Comeback (InvestorPlace)
Aug-01-17 11:21AM	Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Before Q2 Earnings (InvestorPlace)
07:41AM	GlaxoSmithKlines 2Q17 Earnings: Business Segments (Market Realist)
Jul-31-17 06:05PM	Bristol-Myers Squibbs 2Q17 Earnings: Opdivo (Market Realist)
Jul-28-17 05:05PM	Eli Lilly in 2Q17: Performance of New Products (Market Realist)
Jul-27-17 07:44AM	Analysts Recommendations for AstraZeneca in 2Q17 (Market Realist)
Jul-25-17 04:25PM	Inside GlaxoSmithKlines 2Q17 Earnings Estimates (Market Realist)
Jul-24-17 01:05PM	Foreign Exchange Impacts Novartiss Growth in 2Q17 (Market Realist)
10:37AM	Johnson & Johnson: Consumer Products in 2Q17 (Market Realist)
Jul-17-17 10:39AM	Analysts Latest Recommendations for Johnson & Johnson (Market Realist)
10:27AM	Novartiss 2Q17 Earnings: Analyst Estimates (Market Realist)
Jul-11-17 09:07AM	Farxiga Could See Robust Demand in International Markets in 2017 (Market Realist)
Jul-10-17 03:10PM	What Lies Ahead for Pharma ETFs in Second Half 2017 (Zacks)
07:39AM	What We Can Expect from Eli Lilly and Company in 2Q17 (Market Realist)
Jul-04-17 10:37AM	Johnson & Johnsons Pharmaceuticals Business in 1Q17 (Market Realist)
07:36AM	Keytrudas Developments in June 2017 (Market Realist)
Jul-03-17 09:10AM	AstraZeneca May Witness a Fall in 2017 Net Profit Margin (Market Realist)
Jun-30-17 05:27PM	Announcing VanEck Vectors Equity ETFs June 2017 Distributions (Business Wire)
Jun-28-17 10:36AM	Pfizers Profitability in 1Q17 (Market Realist)
Jun-21-17 09:08AM	Analyzing Bristol-Myers Squibbs Valuation on June 20 (Market Realist)
Jun-20-17 12:09PM	SK Biotek to Acquire Manufacturing Facility in Swords, Ireland (Market Realist)
Jun-08-17 09:06AM	What Drove Pfizer in 1Q17? (Market Realist)
Jun-02-17 07:36AM	Inside Novartiss Generics Business Now (Market Realist)

VanEck Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

open in yahoo | open in marketwatch | open in google

PPH

VanEck Pharmaceutical ETF

Upgrade your FINVIZ experience